4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: a systematic review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          We conducted a systematic review to characterize and critically appraise developed prediction models based on structured electronic health record (EHR) data for adverse drug event (ADE) diagnosis and prognosis in adult hospitalized patients.

          Materials and Methods

          We searched the Embase and Medline databases (from January 1, 1999, to July 4, 2022) for articles utilizing structured EHR data to develop ADE prediction models for adult inpatients. For our systematic evidence synthesis and critical appraisal, we applied the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS).

          Results

          Twenty-five articles were included. Studies often did not report crucial information such as patient characteristics or the method for handling missing data. In addition, studies frequently applied inappropriate methods, such as univariable screening for predictor selection. Furthermore, the majority of the studies utilized ADE labels that only described an adverse symptom while not assessing causality or utilizing a causal model. None of the models were externally validated.

          Conclusions

          Several challenges should be addressed before the models can be widely implemented, including the adherence to reporting standards and the adoption of best practice methods for model development and validation. In addition, we propose a reorientation of the ADE prediction modeling domain to include causality as a fundamental challenge that needs to be addressed in future studies, either through acquiring ADE labels via formal causality assessments or the usage of adverse event labels in combination with causal prediction modeling.

          Related collections

          Most cited references77

          • Record: found
          • Abstract: found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

          David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Rayyan—a web and mobile app for systematic reviews

            Background Synthesis of multiple randomized controlled trials (RCTs) in a systematic review can summarize the effects of individual outcomes and provide numerical answers about the effectiveness of interventions. Filtering of searches is time consuming, and no single method fulfills the principal requirements of speed with accuracy. Automation of systematic reviews is driven by a necessity to expedite the availability of current best evidence for policy and clinical decision-making. We developed Rayyan (http://rayyan.qcri.org), a free web and mobile app, that helps expedite the initial screening of abstracts and titles using a process of semi-automation while incorporating a high level of usability. For the beta testing phase, we used two published Cochrane reviews in which included studies had been selected manually. Their searches, with 1030 records and 273 records, were uploaded to Rayyan. Different features of Rayyan were tested using these two reviews. We also conducted a survey of Rayyan’s users and collected feedback through a built-in feature. Results Pilot testing of Rayyan focused on usability, accuracy against manual methods, and the added value of the prediction feature. The “taster” review (273 records) allowed a quick overview of Rayyan for early comments on usability. The second review (1030 records) required several iterations to identify the previously identified 11 trials. The “suggestions” and “hints,” based on the “prediction model,” appeared as testing progressed beyond five included studies. Post rollout user experiences and a reflexive response by the developers enabled real-time modifications and improvements. The survey respondents reported 40% average time savings when using Rayyan compared to others tools, with 34% of the respondents reporting more than 50% time savings. In addition, around 75% of the respondents mentioned that screening and labeling studies as well as collaborating on reviews to be the two most important features of Rayyan. As of November 2016, Rayyan users exceed 2000 from over 60 countries conducting hundreds of reviews totaling more than 1.6M citations. Feedback from users, obtained mostly through the app web site and a recent survey, has highlighted the ease in exploration of searches, the time saved, and simplicity in sharing and comparing include-exclude decisions. The strongest features of the app, identified and reported in user feedback, were its ability to help in screening and collaboration as well as the time savings it affords to users. Conclusions Rayyan is responsive and intuitive in use with significant potential to lighten the load of reviewers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

              The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) Statement includes a 22-item checklist, which aims to improve the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. This explanation and elaboration document describes the rationale; clarifies the meaning of each item; and discusses why transparent reporting is important, with a view to assessing risk of bias and clinical usefulness of the prediction model. Each checklist item of the TRIPOD Statement is explained in detail and accompanied by published examples of good reporting. The document also provides a valuable reference of issues to consider when designing, conducting, and analyzing prediction model studies. To aid the editorial process and help peer reviewers and, ultimately, readers and systematic reviewers of prediction model studies, it is recommended that authors include a completed checklist in their submission. The TRIPOD checklist can also be downloaded from www.tripod-statement.org.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Am Med Inform Assoc
                J Am Med Inform Assoc
                jamia
                Journal of the American Medical Informatics Association : JAMIA
                Oxford University Press
                1067-5027
                1527-974X
                May 2023
                20 February 2023
                20 February 2023
                : 30
                : 5
                : 978-988
                Affiliations
                Amsterdam UMC location University of Amsterdam , Department of Medical Informatics , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Amsterdam UMC location University of Amsterdam , Department of Intensive Care Medicine , Amsterdam, The Netherlands
                Amsterdam UMC location University of Amsterdam , Department of Medical Informatics , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Amsterdam UMC location University of Amsterdam , Department of Medical Informatics , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis , Amsterdam, The Netherlands
                Amsterdam UMC location University of Amsterdam , Department of Medical Informatics , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Amsterdam UMC location Vrije Universiteit Amsterdam , Department of Clinical Chemistry , Amsterdam, The Netherlands
                Amsterdam UMC location University of Amsterdam , Department of Medical Informatics , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Amsterdam UMC location University of Amsterdam , Department of Medical Informatics , Amsterdam, The Netherlands
                Amsterdam Public Health , Amsterdam, The Netherlands
                Author notes
                Corresponding Author: Izak A.R. Yasrebi-de Kom, MSc, Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Meibergdreef 9, Amsterdam, The Netherlands; i.a.r.dekom@ 123456amsterdamumc.nl
                Author information
                https://orcid.org/0000-0002-8655-2521
                Article
                ocad014
                10.1093/jamia/ocad014
                10114128
                36805926
                cbfee611-df06-412f-979c-f6cde38f15aa
                © The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 October 2022
                : 13 January 2023
                : 30 January 2023
                : 01 February 2023
                Page count
                Pages: 11
                Funding
                Funded by: Towards a leaRning mEdication Safety;
                Funded by: The Netherlands Organization for Health Research and Development;
                Award ID: 848018004
                Categories
                Review
                AcademicSubjects/MED00580
                AcademicSubjects/SCI01060
                AcademicSubjects/SCI01530

                Bioinformatics & Computational biology
                adverse drug events,prediction models,electronic health records,hospitals,machine learning

                Comments

                Comment on this article